LENZ Therapeutics, Inc. (LENZ)
NASDAQ·Healthcare·Biotechnology
$6.77
+4.23%
Mkt Cap $219.79M
Analyst Ratings
Buy
5
Hold
1
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+77.3%
Consensus $12.00 vs current $6.77
NASDAQ·Healthcare·Biotechnology
$6.77
+4.23%
Mkt Cap $219.79M
Buy
5
Hold
1
Sell
0
Price Target (6 analysts)
$12.00
Range $12.00 – $12.00
+77.3%
Consensus $12.00 vs current $6.77